|
HS Code |
766315 |
| Chemical Name | 5-bromo-1H-pyrazolo[3,4-c]pyridine |
| Molecular Formula | C6H4BrN3 |
| Molecular Weight | 198.03 g/mol |
| Cas Number | 619320-82-4 |
| Appearance | Off-white to light brown solid |
| Purity | Typically ≥ 97% |
| Solubility | Soluble in DMSO, slightly soluble in methanol |
| Smiles | Brc1n[nH]c2ncccc12 |
| Inchi | InChI=1S/C6H4BrN3/c7-5-4-2-1-3-8-6(4)10-9-5/h1-3H,(H,8,9,10) |
| Storage Conditions | Store at room temperature, in a dry place |
| Synonyms | 5-Bromo-pyrazolo[3,4-c]pyridine |
As an accredited 5-bromo-1H-pyrazolo[3,4-c]pyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The 5-bromo-1H-pyrazolo[3,4-c]pyridine is packaged in a 5g amber glass vial with a tamper-evident screw cap label. |
| Container Loading (20′ FCL) | 20′ FCL loads 7.2MT of 5-bromo-1H-pyrazolo[3,4-c]pyridine, packed in 25kg fiber drums, securely palletized for transport. |
| Shipping | **Shipping Description for 5-bromo-1H-pyrazolo[3,4-c]pyridine:** This chemical is shipped in sealed, labeled containers under ambient or recommended storage conditions. Packaging complies with standard safety regulations for handling research chemicals. Documentation, including safety data, accompanies the shipment. Ensure prompt receipt and proper storage upon delivery. Handle with appropriate personal protective equipment and follow all local regulations. |
| Storage | Store 5-bromo-1H-pyrazolo[3,4-c]pyridine in a tightly sealed container, protected from light and moisture, in a cool, dry, and well-ventilated area. Keep away from incompatible substances such as strong oxidizers and bases. Ensure proper labeling and avoid exposure to heat or sources of ignition. Use appropriate personal protective equipment when handling to prevent inhalation or skin contact. |
| Shelf Life | 5-bromo-1H-pyrazolo[3,4-c]pyridine should be stored in a cool, dry place; shelf life is typically two years. |
|
Purity 98%: 5-bromo-1H-pyrazolo[3,4-c]pyridine with a purity of 98% is used in pharmaceutical intermediate synthesis, where it ensures high yield of target drug compounds. Melting point 235°C: 5-bromo-1H-pyrazolo[3,4-c]pyridine featuring a melting point of 235°C is used in high-temperature reaction processes, where it maintains structural integrity under heat. Molecular weight 196.04 g/mol: 5-bromo-1H-pyrazolo[3,4-c]pyridine of molecular weight 196.04 g/mol is used in medicinal chemistry research, where precise molar calculations enable accurate compound formulation. Particle size <10 µm: 5-bromo-1H-pyrazolo[3,4-c]pyridine with a particle size below 10 µm is used in advanced formulation development, where uniform dispersion enhances bioavailability. Stability temperature 120°C: 5-bromo-1H-pyrazolo[3,4-c]pyridine stable up to 120°C is used in chemical storage and transport, where thermal stability minimizes decomposition risks. |
Competitive 5-bromo-1H-pyrazolo[3,4-c]pyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@boxa-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@boxa-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Fresh chemical names can read like riddles to those outside the lab. 5-bromo-1H-pyrazolo[3,4-c]pyridine might not mean much at first glance, unless you’ve spent some time with fine crystals, reaction vessels, or an HPLC in your hands. There’s always that moment where you weigh the value of a new building block—does it offer something that can save time during synthesis, improve results, or serve as a way to approach a stubborn molecular scaffold?
Chemical model numbers feel like strings of numbers and letters, but here, each bit carries weight. 5-bromo-1H-pyrazolo[3,4-c]pyridine stands out because of its specific substitution on the pyrazolopyridine core. That bromo group at the five position opens a wide doorway for Suzuki couplings or other cross-coupling approaches, giving chemists direct access to analog construction. Not every base molecule manages this balancing act—being stable on the shelf, yet ready to spring into action when a reaction mixture starts stirring.
Purity is critical. Most research labs look for products where impurities won’t muddy downstream steps. Reliable vendors offer this compound often above 98% purity, passing HPLC or NMR inspection, without confusing byproducts or residual solvents. Handling is straightforward, dry and protected from excessive heat or sunlight, as standard with bromo-containing heterocycles. Shipments arrive as pale to off-white powders, fitting easily into the rhythm of medicinal and high-throughput labs.
Every time I or a colleague tried to upgrade an aromatic core, the trouble usually came from clashing functional groups or poor leaving groups. Halogenated heterocycles like this one dodge much of that frustration. Put simply, the bromine on this molecule behaves with just the right touch—reactive during desired transformations but not wily enough to cause runaway side reactions under standard air and temperature.
In drug discovery, especially at the hit expansion stage, versatility within the heterocyclic core can nudge a stalled series toward something more promising. Standard indoles and pyridines might look familiar, but adding the fused pyrazolopyridine motif, plus a well-placed bromo, hands over a different electronic profile. Medicinal chemists keep reaching for these backbones to retrofit kinase inhibitors and probe molecules, distinctly because the pyrazolopyridine structure influences hydrogen bonding patterns with target enzymes, and finds a groove in biological pockets where plain scaffolds fall short.
Compared to similar molecules with methyl or chloro substitutions, bromine punches above its weight for downstream chemistry. I’ve tried using chlorinated versions in parallel, but the rate differences in palladium-catalyzed coupling tell the story—reactions run cleaner and faster on the bromo. That doesn’t just shave time off the synthesis calendar, it also reduces byproduct headaches when you’re scaling up beyond mouse trial quantities.
Building a library of new compounds turns into a wrestling match if starting blocks resist modification. The structure of 5-bromo-1H-pyrazolo[3,4-c]pyridine gives chemists a clear path: synthesize derivatives without losing control, cover plenty of chemical space, and preserve that all-important nitrogen edge that anchors the molecule into new potential binders. Academic and pharmaceutical teams chase diversity, and having a well-behaved bromo heterocycle greases the wheels.
Several colleagues pointed out that using this compound, their first-pass yields frequently landed above 70%, even with novice postdocs running extractions and column chromatography between classes. The crystal structure guides, freely available now in many chemical databases, let you model and predict binding in silico with less guesswork. That matters a lot more since most major research programs run at the edge of time and grant dollars.
Where does this molecule land in real applications? Mostly at the beginning of big ideas. Medicinal chemistry teams in biotech and pharma rely on it for building kinase inhibitor candidates and other enzyme blockers. The same nitrogen arrangement in the fused ring system shows up in scaffolds that have hit clinical trials. Organic chemists need something ready to join a broader skeleton, with minimal interference elsewhere.
Project after project, I saw this kind of synthon used as a core for quick access to libraries aimed at enzyme targets—PKIs, PI3K, and even some G-protein coupled receptor ligands rely on these backbones. Chemical biology programs reach for them, too, where photoreactive tags or fluorescent groups must join a rigid, biologically visible platform. In the hands of a skilled research group, the options multiply: add aryls, tweak the core for solubility or metabolic stability, or bolt on handles for biotinylation or isotope labelling.
This adaptability draws a clear line between 5-bromo-1H-pyrazolo[3,4-c]pyridine and more familiar building blocks like simple bromo-benzenes or pyridines. Each class brings options, but the fused ring here provides enrichment—enough novelty to cross tricky enzyme doors, but stability to permit process chemistry beyond the flasks of a research bench.
The past ten years have seen a consistent march of studies featuring this molecule or its close relatives. A 2022 survey in the Journal of Medicinal Chemistry found that heterocyclic structures with carefully chosen halogenation patterns like this outpaced new indole derivatives for density of biological hits. Some of the more celebrated kinase inhibitors on the market today started from variations on the pyrazolopyridine backbone, and the bromo group, more than the chloro or iodo, offered efficient analog synthesis without the tendency to curl up into hard-to-purify masses.
If you leaf through chemical supplier catalogs and compare pricing or availability, you’ll notice that bromo derivatives stay in steady circulation, not as loss leaders, but because demand from synthetic teams remains high. Lab groups keep asking for larger quantities, and trickling innovation comes from how well these intermediates handle a punishing gauntlet of chemical transformations.
Designing a new series feels more like building a toolkit than picking pieces off a shelf. I’d argue that the value in 5-bromo-1H-pyrazolo[3,4-c]pyridine comes less from its uniqueness than its reliability. With today’s fast SAR cycles and the pressure to meet milestones, teams care less about obscure capabilities and more about predictable performance. Sitting with colleagues over coffee, the conversation often shifts from “what’s cool” to “what works”.
While it’s tempting to seek flashier or more complex building blocks, many groups keep circling back to the basics. The pyrazolopyridine structure, bromo at five, lines up perfectly—easy to model, compatible with broad base-catalyzed and transition metal-catalyzed methods, and forgiving in the hands of early-career chemists. Designing parallel routes, the molecule’s solubility in both polar and non-polar solvents prevents frustrating dead-ends midway through a heavy screening program.
Experimentalists, whether in academia or industry, benefit from not having to spend days troubleshooting failed couplings or dealing with ‘gunked up’ reaction mixtures. Halogenated heterocycles have a reputation for being grumpy, but in practice, this one delivers, sparing researchers extra labor.
Comparing 5-bromo-1H-pyrazolo[3,4-c]pyridine to other popular brominated aromatics, two differences catch the eye. First, the electronic distribution over this fused system damps the tendency for unwanted reactions—an edge over smaller, monocyclic variants. The extra nitrogen atoms introduce different electron flow, translating into superior selectivity during metal-catalyzed reactions. I’ve lost count of the times other bromo-pyridines gave mixtures or polymerized junk, while this structure stayed on track.
Second, modifications at the pyridine ring let medicinal chemists manage off-target liabilities more efficiently. Unlike simple benzo derivatives that readily oxidize or decompose under stress, this system hangs together, maintaining integrity through both chemical and biological screens. That stability matters as molecules head from the bench toward more demanding preclinical or manufacturing settings.
In terms of cost, while some specialty heterocycles fetch eye-watering prices, this one remains accessible enough for screening libraries or academia-funded studies. Vendors respond with regular restocks, and international customs records confirm that shipments move across borders for both EU and US-based researchers every quarter.
Even successful molecules can introduce headaches at certain synthetic steps. For 5-bromo-1H-pyrazolo[3,4-c]pyridine, early routes produced side products that proved tough to separate. Vendors familiar with this chemistry cleaned up the process with better crystallization, improved solvent selection, and sharper quality controls—sometimes after persistent calls from lab-based customers.
The remaining challenge for buyers boils down to scale. While milligram to gram quantities ship reliably, bulk-up for pilot studies takes more planning. Researchers with on-site kilo labs work around this by prepping modest stashes and storing the compound under argon in dryboxes. Some collaborators have found that splitting up purchases across multiple trusted vendors shields their research from unexpected stockouts, which can derail six months of planning.
If your team faces a supply bottleneck, opening long-term relationships with smaller, high-touch vendors can help. Smaller companies often have more flexible lead times and faster response rates when times get tight. Several academic purchasing managers I know go this route to handle unpredictable demand, especially over summer crunch periods.
Recent progress in DNA-encoded library (DEL) technology puts 5-bromo-1H-pyrazolo[3,4-c]pyridine in the spotlight. The structure adapts well to DEL workflows, lending itself to combinatorial expansion and barcode attachment without falling apart during repeated cycles. As DEL advances, more teams look to heterocycles that adapt to robust linkers and tags, which is a sweet spot for this compound.
Another area that’s heating up lies at the interface of chemistry and data science. Machine learning-guided synthesis depends on reliable, well-studied building blocks. This one’s crystalline fingerprints, reaction scope, and bioassay profiles populate growing public and proprietary datasets, cementing its profile for algorithm-driven molecule design programs.
Analytical teams report consistent spectra for the compound—clear NMR, stable mass, and straightforward chromatographic signatures. That repeatability smooths out onboarding for new hires and makes remote collaborations possible, since QC analysts can trust the standards. Labs that hold batch reserves for known active molecules also appreciate the low hazard profile; with proper handling, the safety data lines up with comparable research chemicals.
Evidence for the practical value of 5-bromo-1H-pyrazolo[3,4-c]pyridine isn’t just buried in publications, but in the casual recommendations chemists pass at conferences. Reputations are built one robust synthesis at a time. For graduate students working on next-generation kinase targets, this compound starts as just another bottle in the fridge, but over time, it turns into the quiet backbone for an entire series of novel analogs.
In one example, a well-known group in Europe selected this compound for midpoint diversification on a new anti-viral scaffold. Their updates—shared in real time over lab group chats—kept pointing to the smooth conversion rates and clean purifications. They completed more than a dozen unique analogs in a week, a reminder that the everyday choices in reagent selection ripple out to impact new molecular discoveries.
Every compound carries an environmental cost, from raw material extraction to disposal post-analysis. The track record on this molecule’s synthesis points to moderate downstream impact. Waste solvents and spent reagents from couplings and oxidations fall within standard regulatory profiles, with scalable cleanup using available neutralization and filtration methods.
Efforts to green up the process, such as using alternative, less toxic solvents or catalytic approaches with recyclable ligands, have picked up momentum over the last five years. Labs working within ISO or REACH-compliant frameworks have reported that their waste streams stay within expected limits when using this chemistry, provided technicians stick to published protocols and take basic precautions with halogenated intermediates.
Continued transparency and consistent reporting, especially in academic settings, foster improvements in procurement and waste reduction. It’s also not uncommon for research leaders to include environmental impact assessments for new project proposals involving this and related compounds, nudging everybody toward smarter consumption.
Open forums, digital workspaces, and conference Q&A bring up recurring questions about process optimization for 5-bromo-1H-pyrazolo[3,4-c]pyridine. Researchers mention subtle points—microwave vs. oil bath heating, ligand choices for coupling, tricks for boosting solubility in picky solvents. That organic sense of peer learning keeps this molecule in circulation and relevant for problem-solvers stretched thin by timelines.
Graduate students sometimes face institutional hurdles to rapid adoption, with centralized purchasing departments slow to approve “non-standard” chemicals. In response, many labs set up informal lending programs or share surplus supplies across research groups, turning an individual’s hunch into a resource for the wider scientific community. Out of this necessity, an informal support network has grown, almost as valuable as technical data in big papers.
Chemistry thrives on dependability, and 5-bromo-1H-pyrazolo[3,4-c]pyridine has earned its stripes not by flash, but by serving as a springboard for discovery. The lessons shared by research groups around the world cement its utility, highlight its reliability, and point to areas for continued improvement in synthesis, distribution, and safe handling. Anyone preparing a new molecular library or refining a lead compound benefits from seeing not just the numbers, purity, or packaging, but also the lived experience behind each bottle pulled from a box. The future for this and similar molecules lies in balanced innovation—steady, responsive, community-driven.